Zobrazeno 1 - 4
of 4
pro vyhledávání: '"F. H. Passam"'
Autor:
M. D. Morgan, F. Burke, C. Biela, L. Harper, C. Gordon, S. P. Young, B. S. Goulden, T. J. Turner-Stokes, C. Pericleous, A. Lambrianides, K. Bell, Y. Ioannou, D. Latchman, D. Isenberg, A. Rahman, I. Giles, J.-Y. Zhang, F. H. Passam, S. Rahgozar, J. C. Qi, B. Giannakopoulos, M. Qi, P. Yu, D. Yu, P. J. Hogg, S. Krilis, S. Haque, C. Rakieh, F. Salway, P. Ho, R. Gorodkin, L. Suan Teh, P. J. Day, I. N. Bruce, T. Y. Lu, M. R. Ehrenstein, D. A. Isenberg, R. M. Faria, S. A. Chambers, A. Pegden, M. Shahbaz-Samavi, J. Hewitt, J. Shelmerdine, Y. Ahmad, A. Peall, S. Whyman, R. Goodfellow, J. Martin, J. Morgan, C. Rhys-Dillon
Publikováno v:
Rheumatology. 49:i119-i122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe9196d5c722a5a91b7d6d4fd4c43704
https://doi.org/10.1093/rheumatology/keq728
https://doi.org/10.1093/rheumatology/keq728
Publikováno v:
International journal of immunopathology and pharmacology. 19(1)
Increased angiogenic activity has been demonstrated in lymphoproliferative diseases including Hodgkin's disease. In the current study, the levels of circulating angiogenic molecules in 60 Hodgkin's patients were determined prior to and after treatmen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a3edb98344de41cb2d108914a1df94b4
https://pubmed.ncbi.nlm.nih.gov/16569354
https://pubmed.ncbi.nlm.nih.gov/16569354
Autor:
M G, Alexandrakis, F H, Passam, E S, Ganotakis, K, Sfiridaki, I, Xilouri, K, Perisinakis, D S, Kyriakou
Publikováno v:
Clinical and laboratory haematology. 25(1)
Interleukin-6 (IL-6) and acute phase proteins are commonly increased in patients with multiple myeloma. Several of these acute phase proteins are believed to predict prognosis and influence survival. We measured interleukin-6 (IL-6), C-reactive prote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56c348438b165fc0cbd70442b2ab30b1
https://pubmed.ncbi.nlm.nih.gov/12542441
https://pubmed.ncbi.nlm.nih.gov/12542441
Autor:
M G, Alexandrakis, D S, Kyriakou, F H, Passam, N, Malliaraki, A V, Christophoridou, N, Karkavitsas
Publikováno v:
Clinical and laboratory haematology. 24(3)
Technetium 99m-2-methoxyisobutil-isonitrile (Tc-99m-MIBI), also called sestaMIBI, has been used successfully to detect malignant tumours at diagnosis. Recently, it has been proposed as a safe and effective tracer in patients with multiple myeloma (MM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0c1d70a6046ed030ff9e364e7fb178c3
https://pubmed.ncbi.nlm.nih.gov/12067279
https://pubmed.ncbi.nlm.nih.gov/12067279